CN Stock MarketDetailed Quotes

603590 Beijing Konruns Pharmaceutical

Watchlist
  • 20.66
  • -0.34-1.62%
Market Closed Sep 13 15:00 CST
3.31BMarket Cap24.16P/E (TTM)

Beijing Konruns Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
52.12%277.33M
1.48%314.2M
-33.32%230.2M
-34.46%344.8M
-67.52%182.31M
-42.53%309.63M
-42.37%345.25M
-47.60%526.09M
-47.26%561.36M
-48.59%538.78M
Transactional financial assets
2.95%382.03M
0.22%341.64M
41.38%396.41M
441.20%271.32M
--371.09M
276.04%340.9M
3,001.66%280.37M
--50.13M
----
-57.43%90.65M
Notes receivable and accounts receivable
-11.44%272.59M
-1.88%253.29M
-4.61%263.96M
38.62%295.01M
33.18%307.79M
40.77%258.15M
18.26%276.72M
-28.69%212.81M
-25.44%231.11M
-9.45%183.38M
-Accounts receivable
-11.44%272.59M
-1.88%253.29M
-4.61%263.96M
38.62%295.01M
33.18%307.79M
40.77%258.15M
18.26%276.72M
-27.10%212.81M
-20.41%231.11M
-0.96%183.38M
Other receivables (including interest and dividends)
-4.29%36.56M
0.04%35.9M
28.22%35.56M
337.82%35.94M
397.23%38.19M
994.83%35.88M
339.47%27.73M
-56.49%8.21M
-61.67%7.68M
-84.82%3.28M
-Other receivable
-4.29%36.56M
----
28.22%35.56M
----
397.23%38.19M
----
339.47%27.73M
----
-61.67%7.68M
----
Advance payment
3.85%30.82M
14.59%28.88M
5.30%12.08M
-15.38%25.6M
8.76%29.67M
-32.32%25.2M
-48.06%11.47M
69.03%30.25M
211.13%27.28M
278.80%37.24M
Inventories
79.99%72.23M
16.51%48.04M
31.02%48.47M
20.98%44.48M
-0.30%40.13M
-5.91%41.23M
-21.33%36.99M
-25.74%36.77M
0.51%40.25M
20.86%43.82M
Receivable financing
-62.83%6.07M
-6.62%11.55M
-4.10%18.86M
202.27%20.45M
259.22%16.34M
113.60%12.37M
89.34%19.67M
--6.77M
--4.55M
--5.79M
Other current assets
-83.80%33.67M
-73.97%56.33M
1,113.07%224.41M
3,265.50%218.32M
3,348.85%207.89M
960.29%216.37M
-7.07%18.5M
35.60%6.49M
-82.52%6.03M
516.71%20.41M
Total current assets
-6.88%1.11B
-12.09%1.09B
20.97%1.23B
43.12%1.26B
35.88%1.19B
34.26%1.24B
7.27%1.02B
-37.03%877.52M
-40.56%878.26M
-39.83%923.36M
Non Current assets
Other equity investment
-10.84%703.53M
16.62%726.15M
29.86%684.31M
48.28%730.68M
54.13%789.03M
15.73%622.65M
-5.99%526.94M
-9.94%492.77M
-12.56%511.91M
-9.76%538.01M
Other non-current financial assets
-0.02%74.26M
-2.21%75.03M
-2.31%74.95M
--74.14M
--74.27M
--76.73M
--76.73M
----
----
----
Long-term equity investment
-30.18%48.36M
-30.05%48.92M
-29.45%49.58M
-62.76%68.38M
-57.90%69.27M
-59.31%69.93M
-48.10%70.28M
126.68%183.63M
102.10%164.54M
108.94%171.87M
Fixed assets
-10.47%207.85M
----
-10.62%219.59M
----
-9.40%232.16M
----
-5.82%245.68M
----
-4.83%256.24M
----
Constru in process
12.37%208.02M
----
4.84%190.8M
----
35.72%185.12M
----
43.00%181.98M
----
133.90%136.41M
----
Productive biological assets
----
----
----
----
----
----
----
----
----
-94.57%39.98K
Intangible assets
-0.99%850.32M
-0.99%852.73M
5.15%854.64M
5.25%856.66M
5.52%858.86M
5.79%861.27M
-0.30%812.75M
-0.27%813.9M
-0.33%813.91M
-0.81%814.1M
Development expenditure
112.01%178.28M
119.62%162.72M
26.15%149.82M
-21.92%101.04M
-33.72%84.09M
-12.14%74.09M
46.49%118.76M
388.73%129.42M
--126.87M
--84.33M
Goodwill
0.00%97.64M
0.00%97.64M
0.00%97.64M
0.00%97.64M
0.00%97.64M
0.00%97.64M
0.00%97.64M
0.00%97.64M
0.00%97.64M
-1.43%97.64M
Long deferred expense
-47.21%693.79K
-54.58%691.26K
-46.62%898.93K
18.52%1.11M
23.20%1.31M
26.84%1.52M
25.92%1.68M
7,082.21%933.69K
7,519.89%1.07M
7,899.22%1.2M
Deferred tax assets
2,567.70%23.44M
3,761.21%32.19M
2,870.53%32.27M
-85.14%1.23M
-89.92%878.49K
-89.95%833.77K
-87.88%1.09M
36.52%8.28M
37.15%8.72M
30.21%8.3M
Usufruct assets
-36.38%5.29M
-80.00%2.08M
-66.67%4.16M
-52.47%6.24M
-44.55%8.32M
-38.39%10.4M
-33.46%12.48M
-36.36%13.13M
104.01%15.01M
--16.88M
Other non current assets
226.62%399.51M
227.61%396.09M
-26.66%192.2M
-47.01%170.82M
-62.07%122.32M
-61.68%120.9M
-17.14%262.07M
305.37%322.38M
415.23%322.5M
638.86%315.55M
Total non current assets
10.86%2.8B
18.79%2.8B
5.93%2.55B
1.93%2.52B
2.79%2.52B
-3.30%2.36B
-0.64%2.41B
20.53%2.47B
20.91%2.45B
20.96%2.44B
Total assets
5.16%3.91B
8.15%3.89B
10.40%3.78B
12.72%3.78B
11.51%3.72B
7.01%3.6B
1.59%3.42B
-2.75%3.35B
-4.99%3.33B
-5.31%3.36B
Liabilities
Current liabilities
Short term loan
37.30%79.06M
341.98%126.75M
--96.93M
--85.94M
--57.59M
--28.68M
----
----
----
----
Notes payable and accounts payable
229.32%107.09M
281.02%88.43M
71.16%82.97M
21.08%41.27M
27.99%32.52M
21.56%23.21M
3.72%48.47M
-2.59%34.08M
-62.71%25.41M
-52.07%19.09M
-Accounts payable
229.32%107.09M
281.02%88.43M
71.16%82.97M
21.08%41.27M
27.99%32.52M
21.56%23.21M
3.72%48.47M
-2.59%34.08M
-62.71%25.41M
-52.07%19.09M
Contract liabilities
89.47%3.4M
62.31%4.32M
122.03%6.49M
1.05%1.43M
31.78%1.79M
21.89%2.66M
142.73%2.92M
128.67%1.41M
-34.60%1.36M
4.89%2.18M
Advance receipts
----
----
----
--36.23K
----
----
----
----
----
----
Salaries payable
25.36%20.82M
13.96%17.44M
32.75%30.22M
20.78%21.07M
-5.31%16.61M
14.53%15.31M
-2.59%22.76M
0.15%17.44M
24.76%17.54M
-36.82%13.36M
Taxs payable
-88.79%3.26M
-95.15%1.93M
-90.68%3.69M
33.27%37.77M
17.92%29.04M
40.97%39.92M
44.94%39.57M
47.51%28.34M
11.99%24.63M
15.71%28.32M
Other payable (including interest and dividends)
55.71%132.18M
69.43%89.84M
88.39%94M
10.10%53.87M
74.42%84.89M
8.98%53.02M
2.59%49.9M
9.89%48.93M
-87.97%48.67M
-88.26%48.65M
-Dividend payable
52.39%47.69M
----
----
----
--31.3M
----
----
----
----
----
-Other payable
57.65%84.48M
----
88.39%94M
----
10.11%53.59M
----
2.59%49.9M
----
-87.97%48.67M
----
Non current liabilities due within one year
9.71%8.93M
2.92%9.02M
4.12%9.07M
-20.45%6.18M
6.07%8.14M
15.46%8.76M
16.14%8.71M
-5.07%7.77M
173.94%7.68M
--7.59M
Other current liabilities
-68.21%15.11K
-29.51%38.65K
26.16%30.41K
-72.85%34.37K
-4.45%47.51K
-64.68%54.83K
10.88%24.11K
57.64%126.57K
-81.61%49.72K
-42.59%155.23K
Total current liabilities
53.82%354.74M
96.82%337.77M
87.62%323.39M
79.28%247.59M
84.02%230.62M
43.78%171.61M
11.37%172.36M
10.46%138.1M
-76.85%125.32M
-77.49%119.36M
Current liabilities
Long term loan
26.72%64.1M
-20.00%40.42M
--43.78M
--48.9M
--50.58M
--50.52M
----
----
----
----
Deferred tax liabilities
-35.69%32.77M
-15.39%37.85M
-6.22%27.78M
21.85%42.39M
34.77%50.96M
7.76%44.73M
-34.19%29.62M
-12.30%34.79M
-16.86%37.81M
-11.95%41.51M
Long term deferred income
-16.97%21.63M
-18.02%22.56M
-18.96%23.49M
-3.35%24.59M
-3.17%26.05M
-3.00%27.52M
-2.86%28.98M
-18.70%25.44M
-17.86%26.91M
-17.16%28.37M
Lease liabilities
306.92%3.84M
----
----
----
-86.98%942.69K
-76.03%2.2M
-66.66%3.71M
-51.31%5.97M
61.96%7.24M
--9.19M
Total non current liabilities
-4.82%122.35M
-19.32%100.82M
52.54%95.05M
75.03%115.88M
78.63%128.54M
58.05%124.97M
-27.52%62.31M
-20.46%66.21M
-13.00%71.96M
-2.85%79.07M
Total liabilities
32.83%477.09M
47.88%438.59M
78.31%418.44M
77.90%363.47M
82.05%359.16M
49.47%296.58M
-2.52%234.68M
-1.89%204.31M
-68.38%197.28M
-67.56%198.42M
Shareholders equity
Paid-in capital
0.00%160M
0.00%160M
0.00%160M
0.00%160M
0.00%160M
0.00%160M
0.00%160M
0.00%160M
0.00%160M
0.00%160M
Capital reserve funds
-2.71%965.57M
-3.24%960.29M
-3.77%955.01M
-4.25%948.54M
0.37%992.46M
0.55%992.46M
0.74%992.46M
0.08%990.63M
1.41%988.81M
1.41%986.99M
Surplus reserve funds
0.00%80M
0.00%80M
0.00%80M
0.00%80M
0.00%80M
0.00%80M
0.00%80M
0.00%80M
0.00%80M
0.00%80M
Retained profit
4.66%2B
7.20%2.01B
6.44%1.97B
6.21%1.97B
4.43%1.91B
1.83%1.88B
3.04%1.85B
3.87%1.85B
4.85%1.83B
4.33%1.84B
Less:Treasury stock
-36.95%78.59M
-36.95%78.59M
-36.95%78.59M
-70.97%36.19M
0.00%124.64M
0.00%124.64M
0.00%124.64M
0.00%124.64M
23.65%124.64M
50.16%124.64M
Other composite income
-112.19%-7.62M
-76.09%11.61M
19.20%-26.5M
119.68%12.93M
226.52%62.53M
278.10%48.54M
-304.51%-32.8M
-237.43%-65.69M
-478.02%-49.42M
-183.42%-27.25M
Shareholders equity without minority interests
1.23%3.12B
3.70%3.14B
4.58%3.06B
8.30%3.13B
6.81%3.08B
3.94%3.03B
1.29%2.93B
0.82%2.89B
0.42%2.89B
-0.39%2.92B
Minority interests
13.04%310.52M
14.61%307.63M
14.47%302.44M
10.63%279.52M
10.06%274.7M
9.19%268.41M
9.27%264.22M
-31.19%252.67M
2,447.86%249.59M
2,409.30%245.82M
Total shareholder equity
2.20%3.43B
4.58%3.45B
5.40%3.36B
8.49%3.41B
7.07%3.36B
4.35%3.3B
1.90%3.19B
-2.81%3.15B
8.73%3.14B
7.64%3.16B
Total liabilityies and equity
5.16%3.91B
8.15%3.89B
10.40%3.78B
12.72%3.78B
11.51%3.72B
7.01%3.6B
1.59%3.42B
-2.75%3.35B
-4.99%3.33B
-5.31%3.36B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds 52.12%277.33M1.48%314.2M-33.32%230.2M-34.46%344.8M-67.52%182.31M-42.53%309.63M-42.37%345.25M-47.60%526.09M-47.26%561.36M-48.59%538.78M
Transactional financial assets 2.95%382.03M0.22%341.64M41.38%396.41M441.20%271.32M--371.09M276.04%340.9M3,001.66%280.37M--50.13M-----57.43%90.65M
Notes receivable and accounts receivable -11.44%272.59M-1.88%253.29M-4.61%263.96M38.62%295.01M33.18%307.79M40.77%258.15M18.26%276.72M-28.69%212.81M-25.44%231.11M-9.45%183.38M
-Accounts receivable -11.44%272.59M-1.88%253.29M-4.61%263.96M38.62%295.01M33.18%307.79M40.77%258.15M18.26%276.72M-27.10%212.81M-20.41%231.11M-0.96%183.38M
Other receivables (including interest and dividends) -4.29%36.56M0.04%35.9M28.22%35.56M337.82%35.94M397.23%38.19M994.83%35.88M339.47%27.73M-56.49%8.21M-61.67%7.68M-84.82%3.28M
-Other receivable -4.29%36.56M----28.22%35.56M----397.23%38.19M----339.47%27.73M-----61.67%7.68M----
Advance payment 3.85%30.82M14.59%28.88M5.30%12.08M-15.38%25.6M8.76%29.67M-32.32%25.2M-48.06%11.47M69.03%30.25M211.13%27.28M278.80%37.24M
Inventories 79.99%72.23M16.51%48.04M31.02%48.47M20.98%44.48M-0.30%40.13M-5.91%41.23M-21.33%36.99M-25.74%36.77M0.51%40.25M20.86%43.82M
Receivable financing -62.83%6.07M-6.62%11.55M-4.10%18.86M202.27%20.45M259.22%16.34M113.60%12.37M89.34%19.67M--6.77M--4.55M--5.79M
Other current assets -83.80%33.67M-73.97%56.33M1,113.07%224.41M3,265.50%218.32M3,348.85%207.89M960.29%216.37M-7.07%18.5M35.60%6.49M-82.52%6.03M516.71%20.41M
Total current assets -6.88%1.11B-12.09%1.09B20.97%1.23B43.12%1.26B35.88%1.19B34.26%1.24B7.27%1.02B-37.03%877.52M-40.56%878.26M-39.83%923.36M
Non Current assets
Other equity investment -10.84%703.53M16.62%726.15M29.86%684.31M48.28%730.68M54.13%789.03M15.73%622.65M-5.99%526.94M-9.94%492.77M-12.56%511.91M-9.76%538.01M
Other non-current financial assets -0.02%74.26M-2.21%75.03M-2.31%74.95M--74.14M--74.27M--76.73M--76.73M------------
Long-term equity investment -30.18%48.36M-30.05%48.92M-29.45%49.58M-62.76%68.38M-57.90%69.27M-59.31%69.93M-48.10%70.28M126.68%183.63M102.10%164.54M108.94%171.87M
Fixed assets -10.47%207.85M-----10.62%219.59M-----9.40%232.16M-----5.82%245.68M-----4.83%256.24M----
Constru in process 12.37%208.02M----4.84%190.8M----35.72%185.12M----43.00%181.98M----133.90%136.41M----
Productive biological assets -------------------------------------94.57%39.98K
Intangible assets -0.99%850.32M-0.99%852.73M5.15%854.64M5.25%856.66M5.52%858.86M5.79%861.27M-0.30%812.75M-0.27%813.9M-0.33%813.91M-0.81%814.1M
Development expenditure 112.01%178.28M119.62%162.72M26.15%149.82M-21.92%101.04M-33.72%84.09M-12.14%74.09M46.49%118.76M388.73%129.42M--126.87M--84.33M
Goodwill 0.00%97.64M0.00%97.64M0.00%97.64M0.00%97.64M0.00%97.64M0.00%97.64M0.00%97.64M0.00%97.64M0.00%97.64M-1.43%97.64M
Long deferred expense -47.21%693.79K-54.58%691.26K-46.62%898.93K18.52%1.11M23.20%1.31M26.84%1.52M25.92%1.68M7,082.21%933.69K7,519.89%1.07M7,899.22%1.2M
Deferred tax assets 2,567.70%23.44M3,761.21%32.19M2,870.53%32.27M-85.14%1.23M-89.92%878.49K-89.95%833.77K-87.88%1.09M36.52%8.28M37.15%8.72M30.21%8.3M
Usufruct assets -36.38%5.29M-80.00%2.08M-66.67%4.16M-52.47%6.24M-44.55%8.32M-38.39%10.4M-33.46%12.48M-36.36%13.13M104.01%15.01M--16.88M
Other non current assets 226.62%399.51M227.61%396.09M-26.66%192.2M-47.01%170.82M-62.07%122.32M-61.68%120.9M-17.14%262.07M305.37%322.38M415.23%322.5M638.86%315.55M
Total non current assets 10.86%2.8B18.79%2.8B5.93%2.55B1.93%2.52B2.79%2.52B-3.30%2.36B-0.64%2.41B20.53%2.47B20.91%2.45B20.96%2.44B
Total assets 5.16%3.91B8.15%3.89B10.40%3.78B12.72%3.78B11.51%3.72B7.01%3.6B1.59%3.42B-2.75%3.35B-4.99%3.33B-5.31%3.36B
Liabilities
Current liabilities
Short term loan 37.30%79.06M341.98%126.75M--96.93M--85.94M--57.59M--28.68M----------------
Notes payable and accounts payable 229.32%107.09M281.02%88.43M71.16%82.97M21.08%41.27M27.99%32.52M21.56%23.21M3.72%48.47M-2.59%34.08M-62.71%25.41M-52.07%19.09M
-Accounts payable 229.32%107.09M281.02%88.43M71.16%82.97M21.08%41.27M27.99%32.52M21.56%23.21M3.72%48.47M-2.59%34.08M-62.71%25.41M-52.07%19.09M
Contract liabilities 89.47%3.4M62.31%4.32M122.03%6.49M1.05%1.43M31.78%1.79M21.89%2.66M142.73%2.92M128.67%1.41M-34.60%1.36M4.89%2.18M
Advance receipts --------------36.23K------------------------
Salaries payable 25.36%20.82M13.96%17.44M32.75%30.22M20.78%21.07M-5.31%16.61M14.53%15.31M-2.59%22.76M0.15%17.44M24.76%17.54M-36.82%13.36M
Taxs payable -88.79%3.26M-95.15%1.93M-90.68%3.69M33.27%37.77M17.92%29.04M40.97%39.92M44.94%39.57M47.51%28.34M11.99%24.63M15.71%28.32M
Other payable (including interest and dividends) 55.71%132.18M69.43%89.84M88.39%94M10.10%53.87M74.42%84.89M8.98%53.02M2.59%49.9M9.89%48.93M-87.97%48.67M-88.26%48.65M
-Dividend payable 52.39%47.69M--------------31.3M--------------------
-Other payable 57.65%84.48M----88.39%94M----10.11%53.59M----2.59%49.9M-----87.97%48.67M----
Non current liabilities due within one year 9.71%8.93M2.92%9.02M4.12%9.07M-20.45%6.18M6.07%8.14M15.46%8.76M16.14%8.71M-5.07%7.77M173.94%7.68M--7.59M
Other current liabilities -68.21%15.11K-29.51%38.65K26.16%30.41K-72.85%34.37K-4.45%47.51K-64.68%54.83K10.88%24.11K57.64%126.57K-81.61%49.72K-42.59%155.23K
Total current liabilities 53.82%354.74M96.82%337.77M87.62%323.39M79.28%247.59M84.02%230.62M43.78%171.61M11.37%172.36M10.46%138.1M-76.85%125.32M-77.49%119.36M
Current liabilities
Long term loan 26.72%64.1M-20.00%40.42M--43.78M--48.9M--50.58M--50.52M----------------
Deferred tax liabilities -35.69%32.77M-15.39%37.85M-6.22%27.78M21.85%42.39M34.77%50.96M7.76%44.73M-34.19%29.62M-12.30%34.79M-16.86%37.81M-11.95%41.51M
Long term deferred income -16.97%21.63M-18.02%22.56M-18.96%23.49M-3.35%24.59M-3.17%26.05M-3.00%27.52M-2.86%28.98M-18.70%25.44M-17.86%26.91M-17.16%28.37M
Lease liabilities 306.92%3.84M-------------86.98%942.69K-76.03%2.2M-66.66%3.71M-51.31%5.97M61.96%7.24M--9.19M
Total non current liabilities -4.82%122.35M-19.32%100.82M52.54%95.05M75.03%115.88M78.63%128.54M58.05%124.97M-27.52%62.31M-20.46%66.21M-13.00%71.96M-2.85%79.07M
Total liabilities 32.83%477.09M47.88%438.59M78.31%418.44M77.90%363.47M82.05%359.16M49.47%296.58M-2.52%234.68M-1.89%204.31M-68.38%197.28M-67.56%198.42M
Shareholders equity
Paid-in capital 0.00%160M0.00%160M0.00%160M0.00%160M0.00%160M0.00%160M0.00%160M0.00%160M0.00%160M0.00%160M
Capital reserve funds -2.71%965.57M-3.24%960.29M-3.77%955.01M-4.25%948.54M0.37%992.46M0.55%992.46M0.74%992.46M0.08%990.63M1.41%988.81M1.41%986.99M
Surplus reserve funds 0.00%80M0.00%80M0.00%80M0.00%80M0.00%80M0.00%80M0.00%80M0.00%80M0.00%80M0.00%80M
Retained profit 4.66%2B7.20%2.01B6.44%1.97B6.21%1.97B4.43%1.91B1.83%1.88B3.04%1.85B3.87%1.85B4.85%1.83B4.33%1.84B
Less:Treasury stock -36.95%78.59M-36.95%78.59M-36.95%78.59M-70.97%36.19M0.00%124.64M0.00%124.64M0.00%124.64M0.00%124.64M23.65%124.64M50.16%124.64M
Other composite income -112.19%-7.62M-76.09%11.61M19.20%-26.5M119.68%12.93M226.52%62.53M278.10%48.54M-304.51%-32.8M-237.43%-65.69M-478.02%-49.42M-183.42%-27.25M
Shareholders equity without minority interests 1.23%3.12B3.70%3.14B4.58%3.06B8.30%3.13B6.81%3.08B3.94%3.03B1.29%2.93B0.82%2.89B0.42%2.89B-0.39%2.92B
Minority interests 13.04%310.52M14.61%307.63M14.47%302.44M10.63%279.52M10.06%274.7M9.19%268.41M9.27%264.22M-31.19%252.67M2,447.86%249.59M2,409.30%245.82M
Total shareholder equity 2.20%3.43B4.58%3.45B5.40%3.36B8.49%3.41B7.07%3.36B4.35%3.3B1.90%3.19B-2.81%3.15B8.73%3.14B7.64%3.16B
Total liabilityies and equity 5.16%3.91B8.15%3.89B10.40%3.78B12.72%3.78B11.51%3.72B7.01%3.6B1.59%3.42B-2.75%3.35B-4.99%3.33B-5.31%3.36B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Huaxing Certified Public Accountants (Special General Partnership)------Huaxing Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data